Vaccine Adjuvants Market Global Industry Analysis 2018-2028: Expanding Human Vaccine Adjuvants Segment and Rising Infectious Disease Threats Propel Market Advancements
February 21, 2024 11:34 ET
|
Research and Markets
Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ...
Global Pneumococcal Vaccine Market to Showcase a 6.26% CAGR till 2028: Next-Gen Pneumococcal Vaccines Revolutionizing Protection, Driving Market Growth Through Combination Products
February 09, 2024 10:06 ET
|
Research and Markets
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Pneumococcal Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ...
Conjugate Vaccines Market Projected at $18.47 Billion by 2028, Driven by Major Advances in Preventive Healthcare and Technology
February 09, 2024 09:46 ET
|
Research and Markets
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Conjugate Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
HilleVax to Present at Guggenheim 6th Annual Biotechnology Conference
February 05, 2024 16:05 ET
|
HilleVax, Inc.
BOSTON, Feb. 05, 2024 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it...
Recombinant Vaccines Research Report 2024: Market Poised for Accelerated Growth, Set to Reach $34.18 Billion by 2034 from $10.14 Billion in 2023
January 31, 2024 11:23 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Recombinant Vaccines Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global...
H1N1 Vaccines Industry Report 2023-2028: North America Leads Charge with Advanced Vaccine Research and Public Health Initiatives
January 29, 2024 07:41 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "H1N1 Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's...
Global Therapeutic BCG Vaccine Market Analysis Report 2023-2028: Increasing Tuberculosis Control Efforts Driving Industry Growth
January 26, 2024 07:34 ET
|
Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Therapeutic BCG Vaccine Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F" report has been added to ...
Plant-based Vaccines Market Industry Analysis and Forecast to 2031 - Promising Avenue for Safer, More Accessible and Cost-Effective Vaccine Development
January 25, 2024 14:11 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Plant-based Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
COVID-19 Vaccines Global Market Outlook to 2026: Trends & Analysis, Epidemiology, Unmet Needs & Opportunities, Therapeutic Landscape, Pipeline Assessment, Clinical Trial Strategies
January 23, 2024 16:03 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "COVID-19 Vaccines Market Size, Trends and Analysis by Disease Overview, Epidemiology, Unmet Needs and Opportunities, Therapeutic Landscape, Pipeline...
HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer
January 18, 2024 07:00 ET
|
HilleVax, Inc.
BOSTON, Jan. 18, 2024 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced the...